|
|
||||||||

*
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, and
Division of Developmental and Clinical Immunology, Department of Microbiology, University of Alabama, Birmingham, AL 35294
The major histocompatability class II heterodimer (class II) is
expressed on the surface of both resting and activated B cells.
Although it is clear that class II expression is required for Ag
presentation to CD4+ T cells, substantial evidence suggests
that class II serves as a signal transducing receptor that regulates B
cell function. In ex vivo B cells primed by Ag receptor (BCR)
cross-linking and incubation with IL-4, or B cell lines such as
K46-17µm
, class II ligation leads to the activation of protein
tyrosine kinases, including Lyn and Syk and subsequent phospholipase
C
-dependent mobilization of Ca2+. In this study,
experiments demonstrated reciprocal desensitization of class II and BCR
signaling upon cross-linking of either receptor, suggesting that the
two receptors transduce signals via common processes and/or effector
proteins. Because class II and BCR signal transduction pathways exhibit
functional similarities, additional studies were conducted to evaluate
whether class II signaling is regulated by BCR coreceptors. Upon
cross-linking of class II, the BCR coreceptors CD19 and CD22 were
inducibly phosphorylated on tyrosine residues. Phosphorylation of CD22
was associated with increased recruitment and binding of the protein
tyrosine phosphatase SHP-1. Similarly, tyrosine phosphorylation of CD19
resulted in recruitment and binding of Vav and phosphatidylinositol
3-kinase. Finally, co-cross-linking studies demonstrated that signaling
via class II was either attenuated (CD22/SHP-1) or enhanced (CD19/Vav
and phosphatidylinositol 3-kinase), depending on the coreceptor that
was brought into close proximity. Collectively, these results suggest
that CD19 and CD22 modulate class II signaling in a manner similar to
that for the BCR.
This article has been cited by other articles:
![]() |
M. Rovedo and R. Longnecker Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase Lyn J. Virol., September 1, 2008; 82(17): 8520 - 8528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, P. M. Waterman, K. R. Jonscher, C. M. Short, N. A. Reisdorph, and J. C. Cambier MPYS, a Novel Membrane Tetraspanner, Is Associated with Major Histocompatibility Complex Class II and Mediates Transduction of Apoptotic Signals Mol. Cell. Biol., August 15, 2008; 28(16): 5014 - 5026. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Kin and V. M. Sanders CD86 Regulates IgG1 Production via a CD19-Dependent Mechanism J. Immunol., August 1, 2007; 179(3): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Nashar and J. R. Drake Dynamics of MHC Class II-Activating Signals in Murine Resting B Cells J. Immunol., January 15, 2006; 176(2): 827 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Mills, J. C. Stolpa, and J. C. Cambier Cognate B Cell Signaling via MHC Class II: Differential Regulation of B Cell Antigen Receptor and MHC Class II/Ig-{alpha}{beta} Signaling by CD22 J. Immunol., January 1, 2004; 172(1): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tuscano, R. T. O'Donnell, L. A. Miers, L. A. Kroger, D. L. Kukis, K. R. Lamborn, T. F. Tedder, and G. L. DeNardo Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts Blood, May 1, 2003; 101(9): 3641 - 3647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bouillon, Y. El Fakhry, J. Girouard, H. Khalil, J. Thibodeau, and W. Mourad Lipid Raft-dependent and -independent Signaling through HLA-DR Molecules J. Biol. Chem., February 21, 2003; 278(9): 7099 - 7107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Knoetig, T. A. Torrey, Z. Naghashfar, T. McCarty, and H. C. Morse III CD19 Signaling Pathways Play a Major Role for Murine AIDS Induction and Progression J. Immunol., November 15, 2002; 169(10): 5607 - 5614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Castaigne, W. Guo, C. Leveille, D. Charron, and R. Al-Daccak A CD18-dependent protein kinase C {beta}-mediated alternative cell death pathway of activated monocytes Int. Immunol., September 1, 2002; 14(9): 1003 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lokshin, P. Kalinski, R. R. Sassi, R. B. Mailliard, J. Muller-Berghaus, W. J. Storkus, X. Peng, A. M. Marrangoni, R. P. Edwards, and E. Gorelik Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II Int. Immunol., September 1, 2002; 14(9): 1027 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Natarajan, N. C. Sahoo, and K. V. S. Rao Signal Thresholds and Modular Synergy During Expression of Costimulatory Molecules in B Lymphocytes J. Immunol., July 1, 2001; 167(1): 114 - 122. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |